Announcing the Finalists for the 2018 Diabetes Innovation Challenge
Dear Partner, Sponsor and Friend,
We have exciting news! Ten Academic research teams and early stage companies were named as finalists in the 2018 Diabetes Innovation Challenge, a world-wide competition to identify, nurture and advance innovative scientific and clinical solutions for diabetes.
This wouldn’t be possible without the generous support of the community and our lead sponsors, The Leona M. and Harry B. Helmsley Charitable Trust and JDRF. Thank you!
The finalists offer proposals in four categories that are critical to advancing the care of people with diabetes including:
Automated Insulin Devices (Artificial Pancreas) and related components such as novel glucose sensing, insulin delivery systems, and cellular therapy delivery technologies
AP Advance: An autonomous and discreet diabetes management system mimicking a healthy pancreas
Cam Med LLC: An ultra-thin, flexible, bandage-like patch pump that delivers multiple drugs at minimal cost
Micromedics, Inc.: A portable bio-artificial pancreas using microfabrication technology to mimic the pancreas
Diagnostics such as novel low-cost tests for research and screening; early diagnosis and prevention; autoantibodies, C- peptide, or other markers such as beta cell death and risk of diabetic complications
Bonbouton: Early detection of signals that can lead to foot ulcers and amputations in diabetic patients
VOTIS Subdermal Imaging Technologies, Ltd.: Pathology of the diabetic foot
Therapeutics including smart insulins, glucagons, immune-modulating therapies, beta cell regeneration and treatments for diabetic complications
Protomer Technologies Inc.: Weekly injectable glucagon that senses low blood sugar and automatically activates in the body
Ridgeline Therapeutics: Oral medication to treat Type 2 diabetes by selectively shrinking fat deposits
University of Southern California: Device to maintain oxygen levels in the eye and prevent blindness
Technology Design/Disease Management solutions for new and disruptive approaches to the use of information and communication technologies to support diabetes management
Capillary Biomedical, Inc.: A soft, multi-port, kink-proof cannula and comfortable, reliable infusion
Integrated Medical Sensors: The world's smallest wireless user-insertable 30-day glucose sensor
Will you join us and be part of the Live Pitch-Off Event on May 21 at the Royal Sonesta Boston?
Seating is limited - REGISTER TODAY!
On May 21, 2018 from 2 to 7PM at the Royal Sonesta Boston, the ten finalists will pitch their solutions during a live event and a panel of judges will select three winners. We will also announce the People's Choice winner.
Attendees will have the opportunity to speak with the 10 finalists and the 20 semifinalists and view their poster presentations.
Thank you!
The 2018 Diabetes Innovation Challenge is generously supported by the following sponsors:
Lead Sponsors:
Platinum Sponsor:
Silver Sponsors:
In-Kind Service Will Be Provided By
Platinum Sponsor:
Prince Lobel Tye, LLP
Silver Sponsors:
CommCreative
M2D2/Massachusetts Medical Device Development Center
Recon Strategy
General Sponsors:
Fortunato Intellectual Property Law
HealthAdvances
Locust Walk
Moody, Famiglietti & Andronico, LLP
ProSciento
Sansum Diabetes Research Institute
Scott Miller Communications
Stacey Shipman
And a Thank You to our Individual Sponsors:
Team Carly Rocks Foundation
The Claire Friedlander Family Foundation
The Geoffrey S. Rehnert Family Charitable Fund
And many individual supporters. Thank you!!
Visit our website for a complete list of sponsors. For more information, contact Robin Lord at rlord@t1dexchange.org.
The Diabetes Innovation Challenge is proudly powered by Skild.
